Published in Curr Med Res Opin on May 01, 2010
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | NCT00393718
GIP and GLP-1, the two incretin hormones: Similarities and differences. J Diabetes Investig (2010) 2.40
Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci (2013) 2.15
Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia). Diabetes Obes Metab (2012) 1.77
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes. Cardiovasc Diabetol (2012) 1.12
Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin-secreting capacity. J Diabetes Investig (2012) 1.10
Fifty-two-week, randomized, multicenter trial to compare the safety and efficacy of the novel glucagon-like peptide-1 analog liraglutide vs glibenclamide in patients with type 2 diabetes. J Diabetes Investig (2011) 1.06
Glucagon-like peptide-1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52-week, randomized, multicenter trial. J Diabetes Investig (2011) 1.01
Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study. Diabetes Obes Metab (2015) 0.94
Liraglutide administration in type 2 diabetic patients who either received no previous treatment or were treated with an oral hypoglycemic agent showed greater efficacy than that in patients switching from insulin. J Diabetes Investig (2012) 0.87
Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function. J Diabetes Investig (2013) 0.86
Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. World J Gastroenterol (2014) 0.83
Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India. Indian J Endocrinol Metab (2014) 0.83
Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin. Diabetes Obes Metab (2014) 0.83
The once-daily human glucagon-like peptide-1 analog, liraglutide, improves β-cell function in Japanese patients with type 2 diabetes. J Diabetes Investig (2012) 0.82
Liraglutide effect in reducing HbA1c and weight in Arab population with type2 diabetes, a prospective observational trial. J Diabetes Metab Disord (2015) 0.81
Liraglutide in adults with type 2 diabetes: global perspective on safety, efficacy and patient preference. Clin Med Insights Endocrinol Diabetes (2011) 0.81
Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallel-group trial. J Diabetes Investig (2015) 0.79
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist. ACS Med Chem Lett (2015) 0.79
A review of newer treatment approaches for type-2 diabetes: Focusing safety and efficacy of incretin based therapy. Saudi Pharm J (2013) 0.79
Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis. Sci Rep (2015) 0.79
Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. PLoS One (2016) 0.77
PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist. Lab Invest (2013) 0.77
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study. Diabetes Obes Metab (2016) 0.76
Incorporating incretin-based therapies into clinical practice for patients with type 2 diabetes. Adv Ther (2014) 0.75
Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting. Indian J Endocrinol Metab (2016) 0.75
Effects of resistant dextrin for weight loss in overweight adults: a systematic review with a meta-analysis of randomized controlled trials. J Pharm Health Care Sci (2017) 0.75
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research. Diabetes Metab Syndr Obes (2017) 0.75
A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetes. Saudi Med J (2016) 0.75
Efficacy of liraglutide therapy in Japanese type 2 diabetic patients insufficiently controlled with basal-supported oral therapy. J Diabetes Investig (2012) 0.75
Efficacy and Clinical Characteristics of Liraglutide in Japanese Patients With Type 2 Diabetes. J Clin Med Res (2015) 0.75
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science (1998) 21.13
Cultures in chimpanzees. Nature (1999) 13.33
Nucleotide sequence divergence and functional constraint in mRNA evolution. Proc Natl Acad Sci U S A (1980) 4.71
The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell (1983) 3.82
Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell (2001) 3.56
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet (1998) 2.80
Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res (1999) 2.61
Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (1999) 2.18
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) (2011) 2.08
A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell (1983) 1.95
Microviscosity and order in the hydrocarbon region of phospholipid and phospholipid-cholesterol dispersions determined with fluorescent probes. Biochemistry (1973) 1.94
A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy. J Pathol (2008) 1.78
Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia). Diabetes Obes Metab (2012) 1.77
Comparison of health appraisals by nurses and physicians. Public Health Rep (1970) 1.72
Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1). Biochem Biophys Res Commun (2000) 1.68
Isolation of chicken vasa homolog gene and tracing the origin of primordial germ cells. Development (2000) 1.67
Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet (1998) 1.65
Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease. Neurology (1998) 1.60
Directional atherectomy prior to stenting in bifurcation lesions: a matched comparison study with stenting alone. Catheter Cardiovasc Interv (2001) 1.59
Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes. Diabetes Obes Metab (2010) 1.57
Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology (2000) 1.57
Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract (2008) 1.55
Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. J Pathol (2001) 1.55
Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia (2007) 1.55
A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology (1998) 1.52
Are physicians sympathetic to superstition? A study of Hinoe-Uma. Soc Biol (1972) 1.49
Myelofibrosis and systemic lupus erythematosus: reversal of fibrosis with high-dose corticosteroid therapy. Acta Haematol (1992) 1.48
Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol (2001) 1.48
Discrepancy between angiography and intravascular ultrasound when analysing small coronary arteries. Eur Heart J (2002) 1.45
Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation (2000) 1.44
cDNA cloning of IL-1 alpha and IL-1 beta from mRNA of U937 cell line. Biochem Biophys Res Commun (1987) 1.41
Assessment of the functional significance of coronary lesions using a monorail catheter. J Invasive Cardiol (2001) 1.39
Late acute thrombosis after coronary brachytherapy: when is the risk over? Catheter Cardiovasc Interv (2001) 1.38
Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea (1999) 1.32
GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes. Diabetes Obes Metab (2011) 1.30
Bifurcation lesions: two stents versus one stent--immediate and follow-up results. J Am Coll Cardiol (2000) 1.29
The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetologia (2011) 1.26
CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem (2001) 1.21
Fibronectin promotes epithelial migration of cultured rabbit cornea in situ. J Cell Biol (1983) 1.18
Laparoscopic intragastric surgery for gastric leiomyoma. Surg Endosc (1997) 1.17
Correlation between cellular ATP level and bile excretion in the rat liver. Transplantation (1985) 1.17
Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation (2000) 1.17
High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem (1993) 1.13
Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function. J Biol Chem (1985) 1.13
Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer. Cancer Lett (1998) 1.12
Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am J Cardiol (2001) 1.12
A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis. Mutat Res (2001) 1.11
Cloning of the fic-1 gene involved in cell filamentation induced by cyclic AMP and construction of a delta fic Escherichia coli strain. J Bacteriol (1988) 1.10
Thoracoscopic enucleation of a large leiomyoma located on the left side of the esophageal wall. Surg Endosc (1997) 1.10
Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem (1998) 1.09
A nucleoside transporter is functionally linked to ectonucleotidases in rat liver canalicular membrane. J Biol Chem (1992) 1.08
Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study. Diabetes Obes Metab (2012) 1.08
Acute aortic dissection in a patient with osteogenesis imperfecta. Ann Thorac Surg (1995) 1.07
Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1. Diabetologia (2003) 1.06
Early cancer and related lesions in the bronchial epithelium in former workers of mustard gas factory. Acta Pathol Jpn (1986) 1.06
Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Br J Cancer (1999) 1.06
Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3'-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene (2006) 1.05
Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH). Ann N Y Acad Sci (2000) 1.05
Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells. J Pathol (2006) 1.05
Cloning and sequencing of an Escherichia coli gene, nlp, highly homologous to the ner genes of bacteriophages Mu and D108. J Bacteriol (1989) 1.05
The biology of the bile canaliculus, 1993. Hepatology (1993) 1.05
Method for measuring the binding of small molecules to proteins from binding-induced alterations of physical-chemical properties. Biochemistry (1972) 1.04
Prevalence of the coexistence of left ventricular false tendons and premature ventricular complexes in apparently healthy subjects: a prospective study in the general population. J Am Coll Cardiol (1988) 1.04
Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens (2006) 1.03
Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy. Br J Ophthalmol (2008) 1.03
Acid phosphatases of rat polymorphonuclear leucocytes. Proc Soc Exp Biol Med (1966) 1.03
Body weights of wild chimpanzees (Pan troglodytes schweinfurthii) of the Mahale Mountains National Park, Tanzania. Am J Phys Anthropol (1987) 1.02
Rapamycin induces autophagy in islets: relevance in islet transplantation. Transplant Proc (2009) 1.02
Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals. Diabetologia (2009) 1.02
The bark-eating habits in primates, with special references to their status in the diet of wild chimpanzees. Folia Primatol (Basel) (1976) 1.02
Fibronectin. A new therapy for corneal trophic ulcer. Arch Ophthalmol (1983) 1.01
MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression. Oncogene (2011) 1.01
Comparison of genome structures among three different strains of avian erythroblastosis virus. Gan (1984) 1.00
Fibronectin enhancement of corneal epithelial wound healing of rabbits in vivo. Arch Ophthalmol (1984) 1.00
Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine-cholesterol vesicles to high density lipoproteins. J Biol Chem (1997) 1.00
Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology (2001) 1.00
Single nucleotide polymorphisms in the gene encoding Krüppel-like factor 7 are associated with type 2 diabetes. Diabetologia (2005) 0.99
Nature of interaction of dextran sulfate with lecithin dispersions and lysolecithin micelles. J Biol Chem (1977) 0.99
Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Diabetes Care (1998) 0.98
Coordination of Lewis acid to eta(2)-enonepalladium(0) leading to continuous structure variation from eta(2)-olefin type to eta(3)-allyl type. J Am Chem Soc (2001) 0.98
Correlation of brightening with cumulative enzyme activity related to lignin biodegradation during biobleaching of kraft pulp by white rot fungi in the solid-state fermentation system. Appl Environ Microbiol (1995) 0.98
Evidence that portal vein decompression improves survival of canine quarter orthotopic liver transplantation. Transplantation (1995) 0.98
Local differences in responses to water among wild chimpanzees. Folia Primatol (Basel) (1980) 0.97
Fibronectin appears at the site of corneal stromal wound in rabbits. Curr Eye Res (1982) 0.97
Ocular surface changes after excimer laser phototherapeutic keratectomy. Ophthalmology (2000) 0.97
Coordinated reassembly of the basement membrane and junctional proteins during corneal epithelial wound healing. Invest Ophthalmol Vis Sci (2000) 0.97
Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy. Lancet (1999) 0.96
Laparoscope-assisted anal sphincter-preserving operation preceded by transanal procedure. Tech Coloproctol (2006) 0.96
Genetic variants at CDC123/CAMK1D and SPRY2 are associated with susceptibility to type 2 diabetes in the Japanese population. Diabetologia (2011) 0.95
Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. Arch Ophthalmol (1997) 0.95
Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24) during fracture healing. Bone (2002) 0.95
Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects. Diabet Med (2004) 0.95
The role of cytokine-induced neutrophil chemoattractant-1 in neutrophil-mediated remote lung injury after intestinal ischaemia/reperfusion in rats. Respirology (2000) 0.95
Fibronectin facilitates corneal epithelial wound healing in diabetic rats. Exp Eye Res (1997) 0.94
Stimulatory effects of fibronectin and EGF on migration of corneal epithelial cells. Invest Ophthalmol Vis Sci (1987) 0.94
Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases. Exp Eye Res (1999) 0.94
Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Gynecol Oncol (1998) 0.93
Multiple activation of mitogen-activated protein kinases by purified independent CCN2 modules in vascular endothelial cells and chondrocytes in culture. Biochimie (2006) 0.93